RIM
CLB icon

Rainier Investment Management’s Core Laboratories CLB Stock Holding History

Rainier Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-22,320
Closed -$2.68M – 156
2016
Q4 		$2.68M Sell
22,320
-410
-2% -$45.4K 0.26% 136
2016
Q3 		$2.55M Sell
22,730
-14,370
-39% -$1.66M 0.17% 161
2016
Q2 		$4.6M Buy
37,100
+2,950
+9% +$356K 0.22% 148
2016
Q1 		$3.84M Buy
34,150
+14,110
+70% +$1.47M 0.17% 172
2015
Q4 		$2.18M Buy
+20,040
New +$2.29M 0.09% 168
2015
Q2 		– Sell
-6,000
Closed -$627K – 185
2015
Q1 		$627K Buy
+6,000
New +$639K 0.01% 181

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Rainier Investment Management's CLB Position: Q1 2017 in Review

Rainier Investment Management sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 22,320 shares — an estimated $2.68M sold.

Rainier Investment Management first reported a position in CLB in Q1 2015 and held it in 6 quarters. The position peaked at $4.6M in Q2 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

  • Rainier Investment Management reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
  • Rainier Investment Management sold 22,320 Core Laboratories shares in Q1 2017, an estimated $2.68M.
  • Rainier Investment Management first reported a position in Core Laboratories in Q1 2015 and held it in 6 quarters.
  • Rainier Investment Management's Core Laboratories position peaked at $4.6M in Q2 2016.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Rainier Investment Management's 13F filing for Q1 2017, filed 12 May 2017.